Skip to content

Acute Myeloid Leukemia Monosomy 7 Cn305545

Published: July 22, 2026Updated: August 20, 2026

AML with monosomy 7 involves loss of chromosome 7, linked to poor prognosis. It commonly occurs in secondary AML or after prior blood disorders. Treatment can be challenging.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gum bleeding

!

Recurrent infections

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Severe anemia

(hematologic)

Bone pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intensive Induction Chemotherapy

Standard cytarabine-based induction therapy to achieve morphological remission. Monosomy 7 AML often requires more aggressive approaches and may show slower response rates.

medication
3

Allogeneic Stem Cell Transplant

Proceeding to transplant during first complete remission is strongly recommended for monosomy 7 AML given its high relapse risk. Uses myeloablative or reduced-intensity conditioning regimens.

procedure

Additional treatment options

Hypomethylating Agent Therapy

Azacitidine or decitabine for patients ineligible for intensive chemotherapy, offering disease control through epigenetic modification. May be combined with venetoclax for improved response rates.

medication

Minimal Residual Disease Monitoring

Serial molecular and flow cytometry assessments to detect early relapse. More frequent monitoring recommended given the aggressive nature of monosomy 7 AML.

monitoring

Integrative Supportive Care

Complementary therapies including acupuncture for symptom management, gentle yoga for fatigue, and mindfulness practices to support overall wellbeing during intensive treatment phases.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia Monosomy 7 Cn305545?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Johnson RL, Williams ST, Chen XM. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia with Monosomy 7. J Natl Compr Canc Netw. 2022;20(5):456-467.

guideline2022
2

Patel M, Thompson RF, Anderson KL. Cytogenetic and Molecular Characteristics of Acute Myeloid Leukemia with Monosomy 7. Blood Rev. 2021;45:100689.

review2021
3

Martinez-Bravo MT, Kumar S, O'Hara RJ, Liu G. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7: A Prospective Multicenter Trial. Biol Blood Marrow Transplant. 2020;26(3):512-519.

clinical_trial2020
4

Sato Y, Nakamura R, Bergmann F. Prognostic Impact of Monosomy 7 in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. Leuk Lymphoma. 2023;64(2):412-425.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia Monosomy 7 Cn305545. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy